07 Jun 23 | 15:59
Sun Pharmaceutical Industries Ltd
Exchange Received Time
Exchange Disseminated Time
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
3/19/2023 12:03:11 AM
Please find enclosed herewith our Press Release relating to 'Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata', which we shall be releasing after sending this letter to you. This is for your information and dissemination.
Copyright@ 2015. All Rights Reserved.
07 Jun 23|18:38 (IST)